This weekend’s Associated Press article on Monsanto’s licensing agreements with companies missed the mark on the real facts behind our business and our licensing approach, including:
- Our business has grown tremendously over the years thanks to a number of factors – an early investment in biotechnology, adding new approaches to historic breeding, and a decision to broadly license the results of those investments to anyone who wanted them, including our biggest direct competitors. We understand this scale of success brings scrutiny.
- The growth of our business cannot be attributed to any forced use by customers or to blocking any competitors.